Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application

MLA

Yuko Kitano, et al. “Generation of Hypoimmunogenic Induced Pluripotent Stem Cells by CRISPR-Cas9 System and Detailed Evaluation for Clinical Application.” Molecular Therapy - Methods & Clinical Development, vol. 26, Sept. 2022, pp. 15–25. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e559c41ba1f7cdb673a72eb7cff5cf06&authtype=sso&custid=ns315887.

APA

Yuko Kitano, Sayaka Nishimura, Tomoaki M. Kato, Anna Ueda, Kaho Takigawa, Masafumi Umekage, Masaki Nomura, Ayane Kawakami, Haruna Ogawa, Huaigeng Xu, Akitsu Hotta, Naoko Takasu, & Masayoshi Tsukahara. (2022). Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application. Molecular Therapy - Methods & Clinical Development, 26, 15–25.

Chicago

Yuko Kitano, Sayaka Nishimura, Tomoaki M. Kato, Anna Ueda, Kaho Takigawa, Masafumi Umekage, Masaki Nomura, et al. 2022. “Generation of Hypoimmunogenic Induced Pluripotent Stem Cells by CRISPR-Cas9 System and Detailed Evaluation for Clinical Application.” Molecular Therapy - Methods & Clinical Development 26 (September): 15–25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e559c41ba1f7cdb673a72eb7cff5cf06&authtype=sso&custid=ns315887.